KBC Group’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Hold |
91,785
| – | – | ﹤0.01% | 664 |
|
|
2026
Q1 | $2.2M | Buy |
91,785
+1,639
| +2% | +$40.1K | 0.01% | 642 |
|
|
2025
Q4 | $2.04M | Hold |
90,146
| – | – | ﹤0.01% | 601 |
|
|
2025
Q3 | $1.82M | Hold |
90,146
| – | – | ﹤0.01% | 608 |
|
|
2025
Q2 | $1.29M | Sell |
90,146
-8,528
| -9% | -$99.7K | ﹤0.01% | 640 |
|
|
2025
Q1 | $1.04M | Sell |
98,674
-224,828
| -69% | -$2.54M | ﹤0.01% | 664 |
|
|
2024
Q4 | $3.92M | Buy |
323,502
+234,840
| +265% | +$3.07M | 0.01% | 537 |
|
|
2024
Q3 | $1.3M | Buy |
88,662
+63
| +0.1% | +$878 | ﹤0.01% | 659 |
|
|
2024
Q2 | $1.28M | Buy |
88,599
+1,577
| +2% | +$25.2K | ﹤0.01% | 639 |
|
|
2024
Q1 | $1.42M | Sell |
87,022
-43,930
| -34% | -$687K | ﹤0.01% | 630 |
|
|
2023
Q4 | $1.95M | Sell |
130,952
-7,056
| -5% | -$79.9K | 0.01% | 610 |
|
|
2023
Q3 | $1.55M | Buy |
138,008
+9,571
| +7% | +$111K | 0.01% | 626 |
|
|
2023
Q2 | $1.29M | Sell |
128,437
-8,284
| -6% | -$76.9K | 0.01% | 665 |
|
|
2023
Q1 | $1.28M | Sell |
136,721
-22,681
| -14% | -$268K | 0.01% | 699 |
|
|
2022
Q4 | $1.95M | Buy |
159,402
+57,832
| +57% | +$721K | 0.01% | 605 |
|
|
2022
Q3 | $1.26M | Buy |
101,570
+790
| +0.8% | +$13.8K | 0.01% | 632 |
|
|
2022
Q2 | $1.98M | Buy |
100,780
+11,949
| +13% | +$283K | 0.01% | 546 |
|
|
2022
Q1 | $2.32M | Sell |
88,831
-18,477
| -17% | -$492K | 0.01% | 558 |
|
|
2021
Q4 | $3.04M | Sell |
107,308
-30,586
| -22% | -$951K | 0.01% | 537 |
|
|
2021
Q3 | $4.4M | Buy |
137,894
+4,374
| +3% | +$147K | 0.02% | 495 |
|
|
2021
Q2 | $4.63M | Buy |
133,520
+23,481
| +21% | +$774K | 0.02% | 483 |
|
|
2021
Q1 | $3.24M | Buy |
110,039
+4,323
| +4% | +$133K | 0.01% | 557 |
|
|
2020
Q4 | $3.24M | Buy |
105,716
+5,290
| +5% | +$161K | 0.01% | 545 |
|
|
2020
Q3 | $2.81M | Sell |
100,426
-21,608
| -18% | -$548K | 0.02% | 528 |
|
|
2020
Q2 | $2.62M | Buy |
122,034
+61,166
| +100% | +$1.35M | 0.02% | 508 |
|
|
2020
Q1 | $1.36M | Buy |
60,868
+1,320
| +2% | +$36.2K | 0.01% | 634 |
|
|
2019
Q4 | $1.75M | Sell |
59,548
-190,173
| -76% | -$5.17M | 0.01% | 717 |
|
|
2019
Q3 | $6.64M | Sell |
249,721
-16,124
| -6% | -$484K | 0.05% | 392 |
|
|
2019
Q2 | $8.99M | Buy |
265,845
+28,320
| +12% | +$919K | 0.07% | 324 |
|
|
2019
Q1 | $7.62M | Buy |
+237,525
| New | +$7.31M | 0.06% | 345 |
|
Other funds holding ELAN
KBC Group's ELAN Position: Q2 2026 in Review
KBC Group held its Elanco Animal Health (ELAN) position steady in Q2 2026 at 91,785 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #664.
KBC Group first reported a position in ELAN in Q1 2019 and has held it in 30 quarters since. The position peaked at $8.99M in Q2 2019. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- KBC Group held 91,785 shares of Elanco Animal Health worth $2.26M as of Q2 2026.
- KBC Group left its Elanco Animal Health share count unchanged in Q2 2026.
- Elanco Animal Health made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #664 holding.
- KBC Group first reported a position in Elanco Animal Health in Q1 2019 and has held it in 30 quarters since.
- KBC Group's Elanco Animal Health position peaked at $8.99M in Q2 2019.
- 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.